CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 151 enrolled
Drug / intervention
Duloxetinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01914666
NCT01914666Phase 3Completed
CompareCT.gov

Phase 3 Clinical Study of Duloxetine Hydrochloride in Patients With CLBP - Open Label Long Term Extension Study

Eli Lilly and Company·interventional·Posted Aug 2, 2013·Updated Jan 27, 2016

In Brief

A Phase 3 clinical trial evaluating Duloxetine for Back Pain Lower Back Chronic. Completed, enrolled 151 participants across 1 site.

Detailed Summary

The purpose of the study is to assess the long term safety of duloxetine in participants with Chronic Low Back Pain (CLBP).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBack Pain Lower Back Chronic
CountriesJapan
CollaboratorsShionogi

Timeline

Phase 3CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedAug 2, 2013
Enrollment StartSep 1, 2013
Primary CompletionDec 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 12.9 years ago

Interventions

Duloxetinedrug

Administered orally